Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Failed lung cancer drug could help shrink breast tumors
June 9th, 2005
Giving women with early breast cancer the drug gefitinib (Iressa) before surgery could reduce the size of their tumors, as well as risk of metastasis, suggest results a randomized trial. Gefitinib has been tested in clinical trials as a treatment for lung cancer but did not help patients live longer overall. Large-scale studies to assess its use in breast cancer, as a treatment prior to surgery, are now being designed, researchers said. Around 80% of breast cancers depend on the hormone estrogen to survive, and removing estrogen from the body is standard treatment for the disease. However, only half of primary breast cancers respond well to this...
Source: Women's Health Weekly (2005-06-09)
|
